Midday movers: Intel, B of A, Vivus
Stocks rise as housing starts climb more than expected.
Intel (INTC) rose nearly 4% after its Q2 earnings beat expectations, in spite of the fact that the company lowered its full-year revenue guidance, citing global economic conditions.
In contrast, Bank of America (BAC) also beat profit expectations and touted its improving capital ratios, but shares slid almost 2%.
Among other notables reporting earnings, Honeywell (HON), Stanley Black & Decker (SWK) and Wynn Resorts (WYNN) advanced, while St. Jude Medical (STJ) and United Rentals (URI) declined.
Among the notable gainers were Vivus (VVUS), up nearly 18%, following FDA approval of its weight-loss drug, and VMware (VMW), up almost 12%, after the company named EMC (EMC) COO Pat Gelsinger as its new CEO and pre-announced better than expected Q2 results.
Among the noteworthy losers were Rovi (ROVI), down over 40%, which was downgraded by at least five firms after the company lowered its outlook for Q2 and the year, and Arena Pharmaceuticals (ARNA), down more than 8%, following the approval of Vivus' Qsymia, which may compete with Arena's lead drug.
MORE ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
The Fed may start tapering in just a few months. Here are a few of the likely winners and losers.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.